Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Breanne Y Farris"'
Autor:
Breanne Y. Farris, Kelly L. Monaghan, Wen Zheng, Courtney D. Amend, Heng Hu, Amanda G. Ammer, James E. Coad, Xuefang Ren, Edwin C. K. Wan
Publikováno v:
Immunity, Inflammation and Disease, Vol 7, Iss 4, Pp 326-341 (2019)
Abstract Introduction Stroke‐associated pneumonia (SAP) is a major cause of mortality in patients who have suffered from severe ischemic stroke. Although multifactorial in nature, stroke‐induced immunosuppression plays a key role in the developme
Externí odkaz:
https://doaj.org/article/cf5c7f3a264d403288c9846512a01c0c
Autor:
Courtney D. Amend, Edwin C. K. Wan, Heng Hu, James E. Coad, Xuefang Ren, Breanne Y. Farris, Wen Zheng, Kelly L. Monaghan, Amanda Gatesman Ammer
Publikováno v:
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease, Vol 7, Iss 4, Pp 326-341 (2019)
Immunity, Inflammation and Disease, Vol 7, Iss 4, Pp 326-341 (2019)
Introduction Stroke‐associated pneumonia (SAP) is a major cause of mortality in patients who have suffered from severe ischemic stroke. Although multifactorial in nature, stroke‐induced immunosuppression plays a key role in the development of SAP
Autor:
Kelly L. Monaghan, Drake Aesoph, Amanda G. Ammer, Wen Zheng, Shokofeh Rahimpour, Breanne Y. Farris, Camille A. Spinner, Peng Li, Jian-Xin Lin, Zu-Xi Yu, Vanja Lazarevic, Gangqing Hu, Warren J. Leonard, Edwin C. K. Wan
Publikováno v:
Proc Natl Acad Sci U S A
Signal transducers and activators of transcription 5 A and B (STAT5A & B) play a critical role in mediating cellular responses following cytokine stimulation. STAT5 proteins critically signal via the formation of dimers through SH2 domain interaction
Publikováno v:
J Vis Exp
Immune cell expansion, activation, and trafficking to the lungs, which are controlled by the expression of multiple cytokines and chemokines, may be altered by severe brain injury. This is evidenced by the fact that pneumonia is a major cause of mort
Autor:
Wen Zheng, Heng Hu, Kelly L. Monaghan, James E. Coad, Courtney D. Amend, Breanne Y. Farris, Edwin C. K. Wan, Xuefang Ren
Stroke-associated pneumonia (SAP) is a major cause of mortality in patients who have suffered from severe ischemic stroke. Although multi-factorial in nature, stroke-induced immunosuppression plays a key role in the development of SAP. Previous studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820de17778a591f1796b4914b5833965
Publikováno v:
Journal of Clinical Oncology. 39:e21147-e21147
e21147 Background: Appropriate molecular testing, biomarker-directed treatment selection, and management of immune-related adverse events (irAEs) are essential best practices for managing patients with mNSCLC who are eligible for IO therapies. Identi
Autor:
Taral Patel, Karim Chamie, Jeffrey D. Carter, Tamar Sapir, Rebecca R Crawford, Manojkumar Bupathi, Sarah P. Psutka, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 39:420-420
420 Background: To align BC treatment with patient goals, it is vital that healthcare providers (HCPs) engage their patients (pts) in SDM for treatment planning. We assessed alignment and discordances on aspects of SDM among BC pts and their urology
Autor:
Maen A. Hussein, Rebecca R Crawford, Jeffrey D. Carter, Taral Patel, Tamar Sapir, Paul M. Barr, Servillano E. Dela Cruz, Michael J. Castine, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 38:231-231
231 Background: Though FL generally has good outcomes, patients with high risk FL have poorer outcomes; proper risk stratification for early intervention has been shown to improve overall benefit in some patients. In a quality improvement (QI) initia
Publikováno v:
Journal of Clinical Oncology. 38:232-232
232 Background: For patients who have ALK or ROS1+ NSCLC, targeted therapies have greatly improved treatment options, though challenges personalizing care have hindered effective integration. In a quality improvement (QI) program conducted in 2 commu
Autor:
Eunice S. Wang, Jeffrey D. Carter, Taral Patel, Maen A. Hussein, Pavani Ellipeddi, Rebecca R Crawford, Tamar Sapir, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 38:e19172-e19172
e19172 Background: For AML patients who are ineligible for intensive induction, novel therapies have greatly improved treatment options, though practice challenges individualizing care have hindered effective integration. In a quality improvement (QI